____________________
MIMS.com Indonesia Drug Update
New Indication: Lucentis (Ranibizumab)
Indication: Treatment of neovascular (wet) age-related macular degeneration (AMD), visual impairment due to diabetic macular edema (DME) or choroidal neovascularisation (CNV) secondary to pathologic myopia (PM).Click to view more information:
http://www.mims.asia/Y94525 – private
galinos | go |